GeneDx Holdings Corp.
- WGS
- NASDAQ
- Medical - Diagnostics & Research
- Genomic Diagnostics
- AI/ML in Healthcare
- Health Data Analytics
$66.29
Today +4.21%Quote Oct 19, 2026, 08:00 PM UTC
−34.43%over the last month
Max drawdown −37.1%From 1-month high −34.4%3 months +7.5%
Our viewPro
The call stays with Pro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
About GeneDx
GeneDx Holdings Corp., a genomics company, provides genetic testing services. The company primarily offers pediatric and rare disease diagnostics with a focus on whole exome and genome sequencing, as well as data and information services.
Where the money comes from
Q2 2026 revenue $226.3M
- Diagnostic Test$111.9M49.4%
- Diagnostic Test, Third Party Insurance$94.7M41.9%
- Diagnostic Test, Institutional Customers$16.1M7.1%
- Product and Service, Other$2.6M1.1%
Sector
Healthcare
Industry
Medical - Diagnostics & Research
Exchange
NASDAQ
Employees
1,300
Founded
2000
Market value
$1.98B
Quote Oct 19
Floor
$66.11
0.3% below price
Resistance
$70.20
5.9% above price
Price vs analyst targets
11 analysts
Lowest target
$63.00Highest target
$90.00
$63.00Highest target
$90.00
- Price $66.29
- Average target $81.00
- Analysts' target range
The price is close to the lowest analyst target. Analysts' average target sits about 22% higher.
The call stays with Pro
7 locked chapters- What to do with this namePro
- Why nowPro
- Why this stockPro
- Section write-upsPro
- Story timelinePro
- News briefPro
- Ask about WGSPro
Verdict, why now, and the write-up open with Pro. New accounts get 14 days of Pro free.
Log in — 14 days free